Back

Reassessing treatment strategies for obstructive prosthetic valve thrombosis: fibrinolysis or urgent surgery?

11 May 2026 (08:30 - 09:15)
Organised by: Logo
Congress Presentation Part of: Hemodynamics, prognostic markers, and precision monitoring in structural heart disease and heart transplantation Treatment HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Bernardo Lisboa Resende

Coimbra Hospital and University Center, Coimbra (Portugal)

6 More presentations in this session

Presentation thumbnail
Survival trajectories in post-transplant patients receiving "acceptably" undersized donor hearts: a long-term analysis
Doctor S. Kumar (Cambridge, GB)
Abstract Slides
Presentation thumbnail
Predictors of heart failure rehospitalization in mitral transcatheter edge-to-edge repair (M-TEER) based on residual mitral regurgitation: a single center study
Doctor M. Biswas (Pittsburgh, US)
Abstract Slides
Presentation thumbnail
Endocarditis by candida spp and association with heart failure: a systematic review of case reports
Doctor C. Vigil Lopez (Ensenada, MX)
Abstract Slides
Presentation thumbnail
Persistent pulmonary hypertension after mitral valve surgery is related to post-operative adverse in-hospital events and mortality.
Miss R. Heijting (Amsterdam, NL)
Abstract Slides
Presentation thumbnail
Predictors of lv function recovery one year after TAVR
Doctor F. Nascimento Ferreira (Lisbon, PT)
Abstract Slides

Access the full session

Session thumbnail
Hemodynamics, prognostic markers, and precision monitoring in structural heart disease and heart transplantation

The Event

Event poster

Heart Failure 2026

11 May 2026 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources